Start Your Search
OA15 - Sublobar Resections for Early Stage NSCLC (ID 396)
- Event: WCLC 2016
- Type: Oral Session
- Track: Surgery
- Presentations: 1
OA15.02 - Survival Outcomes in Sublobar Resection for Clinical T1N0M0 Non-Small Cell Lung Cancer: Wedge Resection or Segmentectomy (ID 4710)
16:00 - 17:30 | Author(s): A. Shimamoto
Lobectomy remains the standard treatment for early-stage non-small cell lung cancer (NSCLC).In practice, however, sublobar resection has been selectively offered for patients with clinical Stage IA NSCLC as curative treatment. To seek optimal surgical procedure for early stage lung cancer, we carried out retrospective analyses of 2122 patients who had undergone limited resection for c-T1N0M0 NSCLC from 26 institutions of Japanese association for chest surgery.
A total of 1963 patients with lobectomy tolerance were eligible for survival analysis. We retrospectively categorized patients of these nodules on numbers of criteria for CT findings; scores were added according to the dominance of ground glass appearance (GGA); >75% = 0, <75% =1, and size of tumor; T1a =0, T1b =1. Statistical analyses were carried out using propensity-matching and Kaplan-Myer with log-rank testing.
We analyzed 1:1 matched 731 patients for segmentectomy and wedge resection with propensity matching.The overall survival (OS) for score 0 group was 90.2% in segmentectomy (n=419) and 94.7% in wedge resection (n=451) (p=0.0351). The disease free survival (DFS) for score 0 group was 90.2% in segmentectomy and 92.7% in wedge resection (p=0.0645). The OS for score 1 group was 93.6% in segmentectomy (n=278) and 80.4% in wedge resection (n=246)(P<0.001)(Fig. 1). The DFS for score 1 group is 94.1% in segmentectomy and 75.3% in wedge resection (P<0.001). The OS for scores 2 was 79.1% in segmentectomy (n=34) and 69.2% in wedge resection (n=34) (p=0.109). The DFS for score 2 group was 87.0% in segmentectomy and 58.1% in wedge resection (p=0.581). Figure 1
This study showed that GGA dominant T1a may be treated by wedge resection where possible. The consolidation dominant T1b did not benefit from sublobar resection. In patients with GGA dominant T1b or consolidation dominant T1a, anatomical segmentectomy with curative intension may provide better prognosis.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.
P3.04 - Poster Session with Presenters Present (ID 474)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 1
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
P3.04-016 - Surgical Implications of the New Lung Adenocarcinoma Classification - Usefulness for Selecting Cases Undergoing Sublobar Resection (ID 3936)
14:30 - 15:45 | Author(s): A. Shimamoto
The 2015 World Health Organization (WHO) Classification of Lung Tumors has just been published and it confirmed a new adenocarcinoma classification based on histomorphologic subtype. We evaluated an appropriateness of new classification in a series in our institute and whether the classification could be useful for selecting limited cases undergoing sublobar resection.
We retrospectively reviewed clinical records of all patients operated on for non-small cell lung cancer from 1997 to 2014 (n=1059). 382 patients (36.1%) had pathological stage IA adenocarcinoma of the lung classified. Pathologists performed histopathologic subtyping according to new 2015 WHO classification. Statistical analyses were made including Kaplan–Meier and Cox regression.
Three overall prognostic groups were identified: low grade: adenocarcinoma in situ (AIS, n=115, 30.1%) and minimally invasive adenocarcinoma (MIA, n=37, 9.7%) had 97.5% and 96.9% of disease-free survival at 5 years (DFS, median follow-up was 72 months); intermediate grade: non-mucinous lepidic adenocarcinoma (n=72, 18.8%), acinar adenocarcinoma (n=72, 18.8%), and papillary adenocarcinoma (n=56, 14.7%), with 84.5%, 83.8%, and 63.1% of DFS; and high grade: invasive mucinous adenocarcinoma (n=11, 2.9%), solid adenocarcinoma (n=14, 3.7%) and micropapillary adenocarcinoma (n=5, 1.3%), with 81.5% of DFS. DFS in low grade was significant better than in other two grades (P<.001), however, there was no significant difference between in intermediate and high grade groups. The recurrent cases in MIA, lepidic, and acinar adenocarcinomas were probably observed papillary component. Preoperative imaging examinations such as consolidation/tumor (C/T) ratio on high resolution CT and maximum standardized uptake value (SUVmax) by FDG-PET were correlated with histopathologic grade according to new classification (P<.05). Moreover, sublobar resection was undergone for 195 cases (51.0%), more cases had been identified small tumor, low C/T ration, low SUVmax, and low grade subtypes, and DFS in sublobar resection was 93.2% which was significant better than in lobectomy (79.5%, P=.0034).
Most of subtypes correlated with DFS, except of papillary adenocarcinoma and subtypes in high grade clinical aggressiveness, which may need more clinical investigation. As papillary components were observed in many recurrent cases, papillary is potentially higher malignancy and could be classified into high grade. Patients in low grade subtypes who underwent sublobar resection had better DFS, which can be predicted using tumor size and preoperative imaging examinations such as C/T ratio and SUVmax. So, the new classification has advantages for better selection of limited cases undergoing sublobar resection as a curative surgery.